Archives

INDIANAPOLIS, Ind. — July 1, 2025 — CAI, a global professional services firm specializing in operational readiness for regulated industries, today announced a strategic partnership...

THE CASE FOR ESG IN PHARMA Growing Pressure to Focus on Sustainability Pharmaceutical manufacturing has been evolving to meet global demands, while maintaining high quality....

Uninterrupted operations are essential in today’s pharmaceutical manufacturing environment. Facilities must deliver consistent output without sacrificing quality, even amid complex infrastructure demands, global supply pressures,...

In highly regulated industries, “Islands of Automation” might sound like streamlined, independent systems working in harmony. But the reality is far from ideal. These disconnected...

A critical challenge persists in today’s biotech and pharmaceutical industries: the shortage of a skilled workforce.  For innovation in biotechnology to thrive, there must be...

In high-stakes industries where failure isn’t an option, “good enough” simply doesn’t cut it. At CAI, rigor is not just a methodology—it’s our mindset. It’s...

Operational Readiness isn’t just a milestone. It’s a designed condition, one that determines whether your facility can deliver compliant, controlled, and efficient production from Day...

Why Invest in a Dark Factory? Pharmaceutical manufacturers are under increasing pressure to meet growing patient demand, accelerate drug development timelines, and adapt to evolving...

Introduction: Why Human Error is a Failing Root Cause  Pharmaceutical manufacturing operates in highly regulated, high-stakes environments where deviations can impact product quality, patient safety,...